RB1 and hepatocellular carcinoma: Studies suggested that HBeAg-mediated upregulation of miR-106b has a role in the HBV-related HCC pathogenesis by targeting the RB gene (Yang et al., 2002; Samal et al., 2017; Stella et al., 2022).